Body composition in childhood inflammatory bowel disease

Anthony E Wiskin1, Stephen A Wootton, Toby M Hunt

  • 1NIHR Biomedical Research Unit (Nutrition, Diet & Lifestyle), Southampton General Hospital, Tremona Road, Southampton, SO16 6YD, UK.

Insights

Children with Inflammatory Bowel Disease (IBD) show varied weight status, with nutritional deficits more prevalent in Crohn's disease. Fat-free mass is linked to disease activity, not just weight, in pediatric Crohn's disease.

Area of Science:

  • Pediatric Gastroenterology
  • Nutritional Science
  • Body Composition Analysis

Background:

  • Impact of Inflammatory Bowel Disease (IBD) on pediatric growth patterns remains incompletely understood.
  • While height and weight deficits are documented in pediatric Crohn's disease, changes in body composition (fat and fat-free mass) are less defined.
  • This study addresses the need to characterize growth and body composition in children with IBD.

Purpose of the Study:

  • To describe the height, weight, and body composition of a cohort of children diagnosed with Inflammatory Bowel Disease (IBD).
  • To investigate the relationship between disease activity and body composition parameters in pediatric IBD patients.

Main Methods:

  • Measurements included height, weight, skinfold thicknesses, and bioelectrical impedance analysis.
  • Disease activity was quantified using established clinical scoring systems.
  • Statistical analysis, including multiple regression, was employed to identify relationships between variables.

Main Results:

  • The cohort comprised 55 children with a median age of 13.7 years.
  • Median Standard Deviation Scores for BMI, height, and weight indicated a range of nutritional status within the cohort.
  • In Crohn's disease, higher disease activity (PCDAI) was significantly associated with lower fat-free mass, independent of overall weight.

Conclusions:

  • Children with IBD exhibit a spectrum of weight status, including both under- and overweight conditions.
  • Nutritional deficits, particularly in fat-free mass, are more pronounced in pediatric Crohn's disease.
  • Disease activity directly impacts lean body mass in pediatric Crohn's disease, highlighting that standard weight or BMI metrics may obscure underlying body composition changes.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...